Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade
Preprint in bioRxiv (December 2023)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Preprint in bioRxiv (December 2023)
Article in Pharmaceutical Fronts (December 2023)
Article in Journal of Surgical Oncology (November 2023)